List view / Grid view
20 May 2019 | By Victoria Rees (European Pharmaceutical Review)
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
17 May 2019 | By European Pharmaceutical Review
The single-use bioprocessing systems market in Asia Pacific has witnessed an impressive rise and is expected to continue growing.
14 May 2019 | By European Pharmaceutical Review
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
7 May 2019 | By European Pharmaceutical Review
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
2 May 2019 | By European Pharmaceutical Review
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
26 April 2019 | By European Pharmaceutical Review
The US government has filed criminal charges against Rochester Drug Co-Operative (RDC), one of the largest pharmaceutical distribution companies in the US, and its former CEO Laurence Doud III and former Chief of Compliance Officer, William Pietruszewski.
25 April 2019 | By Nikki Withers (European Pharmaceutical Review)
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.
23 April 2019 | By European Pharmaceutical Review
More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs.
10 April 2019 | By European Pharmaceutical Review
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
5 April 2019 | By European Pharmaceutical Review
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
19 March 2019 | By Nikki Withers (European Pharmaceutical Review)
Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration...
14 March 2019 | By Nikki Withers (European Pharmaceutical Review)
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
5 March 2019 | By Nikki Withers (European Pharmaceutical Review)
The generic version will cost 50 percent less that the current Humalog list price...
4 March 2019 | By Iqra Farooq (European Pharmaceutical Review)
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
28 February 2019 | By European Pharmaceutical Review
The CMA provisionally finds Auden Mckenzie and Waymade broke the law by agreeing not to compete for the supply of hydrocortisone tablets to the NHS...
Follow: